medcelerator · clinician one-pager
Once-Weekly Oral Medicine for Kids’ BRAF Brain Tumors
Ojemda (tovorafenib) — once-weekly oral RAF inhibitor for BRAF-altered pediatric low-grade glioma
Health Canada/FDA Approved · United States, Canada, Switzerland, European Union · October 9, 2026
Condition: Pediatric Low-Grade Glioma
Who this is for
This is for children and young people — and caregivers — facing relapsed or refractory pediatric low-grade glioma with a BRAF fusion, rearrangement, or V600 mutation after prior systemic therapy. It explains US accelerated approval of Ojemda (tovorafenib), European Commission conditional authorisation (20 April 2026), Swissmedic temporary authorisation (5 May 2026), Health Canada NOC/c (13 July 2026; Ipsen Canada; DINs 02569817 / 02569876), the FIREFLY-1 trial (NCT04775485), once-weekly BSA-based oral tablets or suspension, key safety (bleeding, skin/sun sensitivity, liver tests, growth), and how to talk with a pediatric neuro-oncology clinic — without treating one country’s carton as another’s, or assuming every plan pays. Authorized is not funded.
Next clinical step
Health Canada and the US Food and Drug Administration (FDA) have approved this medicine. In Canada and the United States, ask your doctor or a specialist whether it suits you. They can write a prescription. Insurance or public drug plan coverage is not guaranteed. In Switzerland and the European Union, authorisation is not confirmed; see Possible routes below if any are listed.
General resources for further research
Canadian Cancer Trials Group
A national network conducting clinical trials for cancer treatment. Patients can search for trials by cancer type and location.
https://www.ctg.queensu.ca/
Canadian Clinical Trial Search Portal (Health Canada)
Health Canada's public search of the drug and biologic clinical trials it has authorised in Canada (phase 1 to 3, since April 2013). Search by condition, drug, or trial status and see where trials are running. It replaced the Health Canada Clinical Trials Database in July 2026. A listing is not enrolment, and Health Canada does not recruit patients: ask your clinician and contact the trial sponsor.
https://clinical-trials-search.canada.ca/en/home
ClinicalTrials.gov
US National Library of Medicine registry of clinical studies. Search by condition, drug, NCT number, and location. A listing is not enrolment, eligibility, or funding. Talk with the trial contact and a clinician before assuming a slot exists.
https://clinicaltrials.gov/
Human Research Switzerland (HumRes) trial search
Public Swiss clinical-trial search on Human Research Switzerland (HumRes). Search studies taking place in Switzerland. A listing is not Swissmedic authorisation and is not enrolment.
https://www.humanforschung-schweiz.ch/en/trial-search/
AI-produced discussion aid; not prescribing instructions. Approval does not establish coverage. Full article: https://medcelerator.com/articles/ojemda-tovorafenib-plgg